Volume 2, Issue 1 - 2026
Role of Anti-EBNA-1 Antibodies in Psoriasis: A Seroprevalence Study
Niki Ntavari, Eleni Patrikiou, Athanasios Gkoutzourelas, Christos Liaskos, Dimitrios P. Bogdanos, Efterpi Zafiriou
2026, 2(1): 5. doi: 10.53941/jmai.2026.100005
Dramatic Reduction of Complement System Factors in Rheumatoid Arthritis Patients Treated with Tocilizumab †
Carlo Perricone, Lorenza Bruno
2026, 2(1): 4. doi: 10.53941/jmai.2026.100004
Why Do Rheumatic Diseases with Pulmonary Fibrosis Rarely Develop Digital Clubbing?
Jozélio Freire de Carvalho, Rodrigo Antonio Brandao Neto, Yehuda Shoenfeld
2026, 2(1): 3. doi: 10.53941/jmai.2026.100003
Malfunction of a Hypothetical Evolved Microeukaryote Microbiome: Birth-Initiated Dysregulation of Immune System, Brain, and Gut
David Smith
2026, 2(1): 2. doi: 10.53941/jmai.2026.100002
A Decade of Progress and Persistent Challenges in Autoimmune Diagnostics: Insights from UK NEQAS (2012–2021)
Dina Patel, Ravishankar Sargur, Nicola Bizzaro, Maria Infantino
2026, 2(1): 1. doi: 10.53941/jmai.2026.100001
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com